Literature DB >> 8712703

Characterization of two urothelium cancer cell lines derived from a blackfoot disease endemic area in Taiwan.

C C Tzeng1, H S Liu, C Li, Y T Jin, R M Chen, W H Yang, J S Lin.   

Abstract

Established cancer cell lines with distinct characteristics are valuable in many aspects of in vitro study pertaining to tumor biology, as well as the possible geographic significance. Two long-term cell lines, BFTC905 and BFTC909, were established from primary transitional cell carcinomas (TCC) of patients from a blackfoot disease endemic area in Taiwan, where the prevalence and standard mortality rates of this cancer are unusually high. BFTC905 derived from a grade III TCC of urinary bladder has an epitheloid morphology, and BFTC909 derived from the sarcomatoid component of a grade III TCC of renal pelvis exhibits a fibroblastic growth pattern. They share similar morphological and immunocytochemical characteristics with the tumors of origin, have multiple chromosomal aberrations, and are tumorigenic in nude mice. BFTC905 reveals a unique homogeneously staining region at 11q13, the amplification of which has been detected in 20% of transitional cell carcinoma. In addition to the rarity of renal pelvic origin, the vimentin expression associated with an aggressive clinical behavior and a relatively high tumorigenicity as demonstrated by BFTC909 cells has also rarely been mentioned in TCC cell lines, but has been well documented in vivo and in vitro in renal cell carcinoma and breast cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8712703

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  21 in total

1.  Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation.

Authors:  Annemarie Greife; Jitka Tukova; Christine Steinhoff; Simon D Scott; Wolfgang A Schulz; Jiri Hatina
Journal:  Tumour Biol       Date:  2015-01-08

2.  Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.

Authors:  Christina Michailidi; Masamichi Hayashi; Sayantan Datta; Tanusree Sen; Kaitlyn Zenner; Oluwadamilola Oladeru; Mariana Brait; Evgeny Izumchenko; Alexander Baras; Christopher VandenBussche; Maria Argos; Trinity J Bivalacqua; Habibul Ahsan; Noah M Hahn; George J Netto; David Sidransky; Mohammad Obaidul Hoque
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-13

3.  Functional analyses and prognostic significance of SFRP1 expression in bladder cancer.

Authors:  Anja Rogler; Emil Kendziorra; Johannes Giedl; Christine Stoehr; Helge Taubert; Peter J Goebell; Bernd Wullich; Michael Stöckle; Jan Lehmann; Sabrina Petsch; Arndt Hartmann; Robert Stoehr
Journal:  J Cancer Res Clin Oncol       Date:  2015-03-04       Impact factor: 4.553

4.  Androgen receptor facilitates the recruitment of macrophages in tumor microenvironment to promote upper urinary tract urothelial cell carcinoma progression.

Authors:  Chi-Cheng Chen; Chi-Ping Huang; Teng-Fu Hsieh; Wei-Kai Chiu; Wen-Ling Chang; Chih-Rong Shyr
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

5.  Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells.

Authors:  Akira Ooki; Asma Begum; Luigi Marchionni; Christopher J VandenBussche; Shifeng Mao; Max Kates; Mohammad Obaidul Hoque
Journal:  Int J Cancer       Date:  2018-02-14       Impact factor: 7.396

6.  Androgen receptor expands the population of cancer stem cells in upper urinary tract urothelial cell carcinoma cells.

Authors:  Chi-Cheng Chen; Teng-Fu Hsieh; Chi-Ping Huang; Ai-Lin Yu; Wen-Lin Chang; Chih-Rong Shyr
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

Review 7.  [Bladder carcinoma cell lines as models of the pathobiology of bladder cancer. Review of the literature and establishment of a new progression series].

Authors:  J Hatina; W Huckenbeck; H Rieder; H-H Seifert; W A Schulz
Journal:  Urologe A       Date:  2008-06       Impact factor: 0.639

8.  The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells.

Authors:  Chih-Rong Shyr; Chi-Cheng Chen; Teng-Fu Hsieh; Chao-Hsiang Chang; Wen-Lung Ma; Shuyuan Yeh; Edward Messing; Tsung-Heng Li; Fu-Yin Li; Chawnshang Chang
Journal:  Endocrine       Date:  2012-08-01       Impact factor: 3.633

9.  Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk.

Authors:  Anja Rogler; Sabine Hoja; Eileen Socher; Elke Nolte; Sven Wach; Wolf Wieland; Ferdinand Hofstädter; Peter J Goebell; Bernd Wullich; Arndt Hartmann; Robert Stoehr
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

10.  Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5.

Authors:  J-L Hsieh; C-L Wu; M-D Lai; C-H Lee; C-S Tsai; A-L Shiau
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.